| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $32.8M | -40.4% |
| SG&A Expense | $18.2M | -29.5% |
| Operating Income | -$48.2M | +40.5% |
| Income Tax | $0 | — |
| Net Income | -$43.6M | +43.0% |
| EPS (Basic) | -$8.45 | -555.0% |
| EPS (Diluted) | -$8.45 | -555.0% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $132.3M | +129.6% |
| Short-term Investments | $41.4M | -31.2% |
| Accounts Receivable | $294K | -93.7% |
| Current Assets | $177.5M | +53.5% |
| Total Assets | $179.4M | +22.3% |
| Current Liabilities | $9.6M | -33.8% |
| Total Liabilities | $10.5M | -74.1% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$36.9M | +45.1% |
| Capital Expenditures | $110K | -65.0% |
| Investing Cash Flow | $20.3M | +306.4% |
| Financing Cash Flow | $133.6M | +4541.2% |
| Free Cash Flow | -$37.0M | +45.2% |
| Stockholders' Equity |
| $168.9M |
| +59.4% |